Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReHui Biopharmaceutical
Hangzhou, Zhejiang, China
- Ownership
- Private
- Development stage
- Other
01
Overview
ReHui Biopharmaceutical is a clinical-stage biotechnology company based in Hangzhou, China, specializing in the development of innovative biological drugs for oncology. The company focuses on multi-functional biologics, including bispecific antibodies, fusion proteins, and antibody-drug conjugates (ADCs), designed to modulate the tumor microenvironment and overcome immune evasion. ReHui's lead program, RH001, is a bifunctional fusion protein targeting PD-L1 and TGF-β that is currently in Phase 1/2 trials for advanced solid tumors. The company's pipeline also features RH002, a Claudin 18.2-targeted ADC, and several bispecific programs aimed at hard-to-treat cancers.
- Therapeutic areas
- Oncology
- Modalities
- Recombinant fusion proteinAntibody-drug conjugateBispecific monoclonal antibodyMonoclonal antibodyBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on ReHui Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReHui Biopharmaceutical.